The Blog dot

Currently browsing: Phenotypic Screening

Back to overview

Automation, miniaturization, cell based assays and 3D cell culture – the new standards for phenotypic screening

By Simon Fogarty

If you’ve decided you need to incorporate phenotypic screening into your discovery program and you know that one of the new generation of automation platforms is the way forward, what factors should influence your choice?

A Q&A session with Kevin Moore, Manager Liquid Handling Product and Applications Management at Tecan, offers a view of what you should consider.

Read more

Better together? Phenotypic screening and target-based screening

by Simon Fogarty

Now that phenotypic screening is well and truly back, how do you take advantage of its many benefits, especially if you’ve already made a considerable commitment to target-based screening? The simple answer is: you combine the two.

Read more

Phenotypic screening means exciting times for drug discovery

By Kevin Moore

Phenotypic screening is back, with exciting implications for the discovery of new and more effective drugs. The reason? Constantly improving cellular technologies and instrumentation, and drug discovery and development programs bringing us closer to truly realizing the potential of precision medicine.

Read more

Country selection

appears to be your location. To view country specific information on the Tecan web site, please accept or change country below.

accept country change country select country

Tecan Cookie Policy

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. Disclaimer